Vimarsana
Biggest News Aggregation in the World

Page 2 - Therapeutics Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutics Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutics Program Today - Breaking & Trending Today

Red Blood Cell Transfusion: 2023 AABB International Guidelines | Bleeding and Transfusion | JAMA - Vimarsana News

Red Blood Cell Transfusion: 2023 AABB International Guidelines | Bleeding and Transfusion | JAMA

Red blood cell transfusion threshold guidelines from the AABB transfusion medicine association have been updated to incorporate an expanded evidence base and to

"Off-the-shelf" cell therapy shows promise for cancers resistant to current treatments, including immunotherapies - Vimarsana News

"Off-the-shelf" cell therapy shows promise for cancers resistant to current treatments, including immunotherapies

New research shows promise for a new era of cell therapy designed to benefit patients with some of the most difficult-to-treat cancers.

NEW STUDY FINDS THAT FITTERFLY DIABETES DIGITAL THERAPEUTICS PROGRAM IMPROVES BLOOD SUGAR LEVELS AND PROMOTES WEIGHT LOSS IN PATIENTS WITH TYPE 2 DIABETES - Vimarsana News

NEW STUDY FINDS THAT FITTERFLY DIABETES DIGITAL THERAPEUTICS PROGRAM IMPROVES BLOOD SUGAR LEVELS AND PROMOTES WEIGHT LOSS IN PATIENTS WITH TYPE 2 DIABETES

/PRNewswire/ -- A new research study published in JMIR Diabetes evaluated the real-world effectiveness of the Fitterfly Diabetes CGM digital therapeutic...

Fitterfly presents outcomes from Digital Therapeutics Platform at 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023), Germany - Vimarsana News

Fitterfly presents outcomes from Digital Therapeutics Platform at 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023), Germany

Mumbai (Maharashtra) [India], March 7 (ANI/PRNewswire): Fitterfly, a leading Indian health-tech company, working in the area of diabetes & metabolic health, recently showcased data from its Digital Therapeutics Technology platform at the 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD 2023) in Berlin, Germany. Fitterfly is the one of the few Indian healthcare companies to have received this opportunity in the last 16 years, thereby putting the company's efforts in the area of DTx on the world map. Besides research studies, this year Fitterfly wa...

Senhwa Biosciences Announces Successful Awardee of Anticancer Pipeline, Pidnarulex, in NIH-Sponsored NExT Program - Vimarsana News

Senhwa Biosciences Announces Successful Awardee of Anticancer Pipeline, Pidnarulex, in NIH-Sponsored NExT Program

TAIPEI and SAN DIEGO, Dec. 1, 2022 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class th...